Indivior PLC (LON:INDV - Get Free Report) fell 17% during trading on Thursday . The company traded as low as GBX 548.71 ($6.95) and last traded at GBX 720.60 ($9.13). 2,904,792 shares changed hands during mid-day trading, an increase of 294% from the average session volume of 737,710 shares. The stock had previously closed at GBX 868 ($11.00).
Analyst Ratings Changes
Separately, Jefferies Financial Group restated a "buy" rating and issued a GBX 1,800 ($22.81) price objective on shares of Indivior in a report on Tuesday, December 17th.
View Our Latest Analysis on Indivior
Indivior Price Performance
The stock has a market capitalization of £1.08 billion, a P/E ratio of -570.87, a PEG ratio of -5.57 and a beta of 0.19. The stock's fifty day moving average is GBX 924.76 and its 200-day moving average is GBX 852.88. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52.
Indivior Company Profile
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Stories
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
